Assessment of AAV Dual Vector Safety in theAbca4-/- Mouse Model of Stargardt Disease. (2020)

First Author: McClements ME
Attributed to:  Developing gene therapy to treat blindness caused by Stargardt Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1167/tvst.9.7.20

PubMed Identifier: 32724727

Publication URI: http://europepmc.org/abstract/MED/32724727

Type: Journal Article/Review

Volume: 9

Parent Publication: Translational vision science & technology

Issue: 7

ISSN: 2164-2591